InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.25
(
0.20%
)
US TECH 100
18,976.00
(
0.00%
)
Dow Jones
40,659.76
(
0.24%
)
Brent Oil
79.17
(
0.00%
)
Bitcoin
59,330.85
(
0.77%
)
Post# of 6072
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Run4It

Send PM Follow Ignore
Followers 29
Posts 5581
Boards Moderated 0
Alias Born 07/21/2009

Run4It

Re: None

Monday, 03/19/2012 11:24:31 AM

Monday, March 19, 2012 11:24:31 AM

Post# of 6072
TLON Feuerstein: FDA Raises Safety Questions on Talon Therapeutic's Drug
Posted on 03/19/12 at 10:26am by Allie Wickman [1]


Notable biotech analyst Adam Feuerstein tweeted [2] on Monday about Talon Therapeutics (OTC: TLON [3]) and how the FDA rose questions regarding safety about Marqibo-associated peripheral neuropathy.

He said via Twitter, $TLON - FDA raises safety questions about Marqibo-associated peripheral neuropathy, notes 15 patients died on treatment".

Currently, shares of Talon are trading up about 2% on the session at $0.99 per share.

nop

http://www.benzinga.com/analyst-ratings/analyst-color/12/03/2433890/feuerstein-fda-raises-safety-questions-on-talon-therapeu
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up